Shu et al. [40] reported that the serum HMGB-1 levels of PM/DM patients with ILD were significantly higher than those of PM/DM patients without ILD, and that patients with higher HMGB-1 levels had significantly worse prognosis than those with lower HMGB-1 levels. The gene discussed is HMGB1; the disease is polymyositis.